Nur Nicholson, Chief Technical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 4,290 shares at $29.96 ($129K) on 2025-01-17, disclosed to the SEC on 2025-01-21.
Seasonal sale ($129k) by Chief Technical Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 2,145 | $64K | 50.0% |
| 2 | $29.96 | 2,145 | $64K | 50.0% |
| Total | $29.96 avg | 4,290 | $129K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $58K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |